234505 Sigma-AldrichCompound 56 - CAS 171745-13-4 - Calbiochem
A cell-permeable, reversible, ATP-competitive, highly potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (IC₅₀ = 6 pM).
More>> A cell-permeable, reversible, ATP-competitive, highly potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (IC₅₀ = 6 pM). Less<<Synonyms: 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 171745-13-4 | C₁₈H₁₈BrN₃O₂ |
| References | |
|---|---|
| References | Bridges, A.J., et al. 1996. J. Med. Chem. 39, 267. |
| Product Information | |
|---|---|
| CAS number | 171745-13-4 |
| ATP Competitive | Y |
| Declaration | Sold under license of U.S. Patent 5,457,105 and European Patent 0,566,266. |
| Form | White solid |
| Hill Formula | C₁₈H₁₈BrN₃O₂ |
| Chemical formula | C₁₈H₁₈BrN₃O₂ |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | EGFR |
| Primary Target IC<sub>50</sub> | 6 pM against EGFR |
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information | |
|---|---|
| R Phrase | R: 40 Limited evidence of a carcinogenic effect. |
| S Phrase | S: 36 Wear suitable protective clothing. |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 234505 | 0 |
Documentation
Compound 56 - CAS 171745-13-4 - Calbiochem SDS
| Title |
|---|
Compound 56 - CAS 171745-13-4 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 234505 |
References
| Reference overview |
|---|
| Bridges, A.J., et al. 1996. J. Med. Chem. 39, 267. |



